Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Current advances in clinical pharmacology within oncology, and its relevance for daily practice

Implementation in clinical practice of therapeutic drug monitoring (TDM) of kinase inhibitors anno 2024

Date

15 Sep 2024

Session

Current advances in clinical pharmacology within oncology, and its relevance for daily practice

Topics

Clinical Research;  Translational Research;  Targeted Therapy;  Management of Systemic Therapy Toxicities

Tumour Site

Breast Cancer;  Non-Small Cell Lung Cancer;  Hepatobiliary Cancers;  Sarcoma

Presenters

Ron Mathijssen

Authors

R.H. Mathijssen

Author affiliations

  • Medical Oncology Department, Erasmus MC Daniel den Hoed Cancer Center, 3075 EA - Rotterdam/NL

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.